TCL Archive NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC April 30, 2010
TCL Archive Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development. January 13, 2006